Fcpm III Services B.v. 13F holdings
Fcpm III Services B.v. reported 10 positions with a total reported value of $750.4M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: NAMS NEWAMSTERDAM PHARMA COMPANY (38.3%), MPLT MAPLIGHT THERAPEUTICS INC (15.4%), DYN DYNE THERAPEUTICS INC (11.4%), VOR VOR BIOPHARMA INC (10.1%), DMRA DAMORA THERAPEUTICS INC (8.5%). Against 2026-03-31 it opened 1 new position and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Fcpm III Services B.v. files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
10 largest of 10 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| NAMS NEWAMSTERDAM PHARMA COMPANY | 8,490,353 | $287.7M | 38.3% |
| MPLT MAPLIGHT THERAPEUTICS INC | 3,226,400 | $115.6M | 15.4% |
| DYN DYNE THERAPEUTICS INC | 3,848,256 | $85.5M | 11.4% |
| VOR VOR BIOPHARMA INC | 4,117,354 | $75.8M | 10.1% |
| DMRA DAMORA THERAPEUTICS INC | 2,441,000 | $63.5M | 8.5% |
| REPL REPLIMUNE GROUP INC | 2,808,368 | $31.1M | 4.1% |
| CBIO CRESCENT BIOPHARMA INC. | 1,677,852 | $30.2M | 4.0% |
| AURA AURA BIOSCIENCES INC | 4,053,775 | $28.8M | 3.8% |
| ENGN ENGENE HOLDINGS INC | 12,510,709 | $17.5M | 2.3% |
| BCYC BICYCLE THERAPEUTICS PLC | 3,468,430 | $14.7M | 2.0% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| AURA AURA BIOSCIENCES INC | 4,053,775 | $28.8M | 3.8% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| NAMS NEWAMSTERDAM PHARMA COMPANY | 9,198,900 | 8,490,353 | -7.7% | $287.7M |
| DYN DYNE THERAPEUTICS INC | 4,644,386 | 3,848,256 | -17.1% | $85.5M |
CIK 2013410 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
